Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Oct 15, 2010

Premium

Prosolia this week named Justin Wiseman president and CEO. Chairman Peter Kissinger has stepped down from his role as interim CEO, and former president Kevin Boscacci has resigned his position and left the company.

Wiseman was previously Prosolia's research director and has been involved with the company since it launched in 2004.

The board of directors also elected John Hertig as a member. Hertig is the executive director of AMIPurdue.


Peter Lewis was appointed this week vice president of finance and administration at Bioscale.

Before joining Bioscale, Lewis worked with Affymetrix, First Boston Pharma, PerkinElmer, and Intron.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.